Granalix is a biotech company developing innovative formulations of natural compounds that increase their bioavailability.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Jerusalem
State: Yerushalayim
Zip:
Country: Israel
Granalix is a biotech company developing innovative formulations of natural compounds that increase their bioavailability. The company&s;s first product, GranaGard, is a submicron self-emulsion formulation of pomegranate seed oil, which contains high concentrations of punicic acid (PA), one of the strongest natural antioxidants. In the GranaGard formulation, PA has been shown to convert in vivo into conjugated linoleic acid, an established neuroprotector, and mitochondrial activity modulator. Granalix was founded in 2013 and is headquartered in Jerusalem, Israel.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|